Isamu Nakasone

643 total citations
46 papers, 452 citations indexed

About

Isamu Nakasone is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Isamu Nakasone has authored 46 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Molecular Medicine and 13 papers in Infectious Diseases. Recurrent topics in Isamu Nakasone's work include Antibiotic Resistance in Bacteria (17 papers), Mycobacterium research and diagnosis (10 papers) and Bacterial Identification and Susceptibility Testing (9 papers). Isamu Nakasone is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Mycobacterium research and diagnosis (10 papers) and Bacterial Identification and Susceptibility Testing (9 papers). Isamu Nakasone collaborates with scholars based in Japan and Myanmar. Isamu Nakasone's co-authors include Nobuhisa Yamane, Jiro Fujita, Tatsuya Tada, Kohei Uechi, Teruo Kirikae, Masao Tateyama, Kayo Shimada, Futoshi Higa, Shusaku Haranaga and Nobuchika Kusano and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY.

In The Last Decade

Isamu Nakasone

44 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isamu Nakasone Japan 13 196 130 123 113 93 46 452
Qiulian Deng China 12 245 1.3× 173 1.3× 112 0.9× 120 1.1× 111 1.2× 37 544
C. J. Henwood United Kingdom 7 281 1.4× 110 0.8× 96 0.8× 164 1.5× 82 0.9× 7 462
Akio Kuga Japan 6 245 1.3× 95 0.7× 191 1.6× 192 1.7× 86 0.9× 10 456
María Diez‐Aguilar Spain 15 254 1.3× 157 1.2× 176 1.4× 92 0.8× 145 1.6× 32 563
Shohiro Kinoshita Japan 11 186 0.9× 103 0.8× 91 0.7× 86 0.8× 90 1.0× 23 463
Nils Olav Hermansen Norway 9 213 1.1× 107 0.8× 200 1.6× 69 0.6× 115 1.2× 18 539
Xiucai Zhang China 13 345 1.8× 76 0.6× 164 1.3× 121 1.1× 111 1.2× 21 517
Lily Siew Yong Ng Singapore 13 295 1.5× 121 0.9× 92 0.7× 127 1.1× 115 1.2× 22 479
Rita Moure Spain 11 256 1.3× 165 1.3× 207 1.7× 244 2.2× 123 1.3× 14 581
Chun-Eng Liu Taiwan 10 194 1.0× 199 1.5× 110 0.9× 198 1.8× 77 0.8× 13 586

Countries citing papers authored by Isamu Nakasone

Since Specialization
Citations

This map shows the geographic impact of Isamu Nakasone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isamu Nakasone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isamu Nakasone more than expected).

Fields of papers citing papers by Isamu Nakasone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isamu Nakasone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isamu Nakasone. The network helps show where Isamu Nakasone may publish in the future.

Co-authorship network of co-authors of Isamu Nakasone

This figure shows the co-authorship network connecting the top 25 collaborators of Isamu Nakasone. A scholar is included among the top collaborators of Isamu Nakasone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isamu Nakasone. Isamu Nakasone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uechi, Kohei, Tatsuya Tada, Kayo Shimada, et al.. (2018). Emergence of a carbapenem-resistant and colistin-heteroresistant Enterobacter cloacae clinical isolate in Japan. Journal of Infection and Chemotherapy. 25(4). 285–288. 15 indexed citations
2.
Uechi, Kohei, Tatsuya Tada, Kyoko Kuwahara‐Arai, et al.. (2018). An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens. Journal of Medical Microbiology. 68(2). 124–131. 10 indexed citations
3.
Tada, Tatsuya, Kohei Uechi, Isamu Nakasone, et al.. (2017). A hemin auxotrophic Enterobacter cloacae clinical isolate with increased resistance to carbapenems and aminoglycosides. Journal of Medical Microbiology. 67(1). 29–32. 4 indexed citations
4.
Uechi, Kohei, Tatsuya Tada, Kayo Shimada, et al.. (2017). A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species. Journal of Clinical Microbiology. 55(12). 3405–3410. 44 indexed citations
5.
Higuchi, Wataru, Kiyohito TAIRA, Isamu Nakasone, et al.. (2011). Nosocomial outbreak of multidrug-resistant USA300 methicillin-resistant Staphylococcus aureus causing severe furuncles and carbuncles in Japan. The Journal of Dermatology. 38(12). 1167–1171. 36 indexed citations
6.
7.
Yamane, Nobuhisa, et al.. (2010). LABORATORY-BASED EVALUATION OF BREAKTHROUGH BACTERIAL CONTAMINATION DURING PREDEPOSIT-TYPE AUTOLOGOUS BLOOD TRANSFUSION PREPARATION. Japanese Journal of Transfusion and Cell Therapy. 56(3). 354–358. 1 indexed citations
8.
Endõ, Ryūichi, et al.. (2010). [A simple disk diffusion test to identify beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae--application of cephalexin, cefsulodin and cefaclor disks].. PubMed. 58(10). 963–71. 1 indexed citations
10.
Kubota, Toru, Futoshi Higa, Nobuchika Kusano, et al.. (2006). Genetic Analyses of Beta-Lactamase Negative Ampicillin-Resistant Strains of <i>Haemophilus influenzae</i> Isolated in Okinawa, Japan. Japanese Journal of Infectious Diseases. 59(1). 36–41. 19 indexed citations
11.
Nakasone, Chikara, Takashi Shinzato, Shusaku Haranaga, et al.. (2006). In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV. Journal of Antimicrobial Chemotherapy. 58(6). 1279–1282. 14 indexed citations
12.
Arakaki, Hajime, Hiroshi Uezato, Kimiko Takei, et al.. (2005). Diagnostic Trial for Cutaneous Mycobacterial Diseases Using a PCR Technique. The Nishinihon Journal of Dermatology. 67(1). 42–48.
13.
Yamane, Nobuhisa, et al.. (1998). [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].. PubMed. 46(7). 719–27. 3 indexed citations
14.
Yamane, Nobuhisa, et al.. (1997). [Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard].. PubMed. 45(7). 689–95. 3 indexed citations
15.
Tateyama, M., Hiroshi Fukuhara, Hiroaki Nakamura, et al.. (1995). In vitro antimicrobial activity of balofloxacin and its therapeutic efficacy in respiratory infections. 43. 281–287. 1 indexed citations
16.
Tateyama, Masao, et al.. (1995). In vitro antimicrobial activity of grepafloxacin and its therapeutic efficacy on respiratory infections. 43. 308–313. 2 indexed citations
17.
Fukuhara, Hiroshi, et al.. (1991). BASIC AND CLINICAL STUDIES ON CEFPIROME IN RESPIRATORY INFECTIONS. Chemotherapy. 39(1). 236–242. 1 indexed citations
18.
Fukuhara, Hiroshi, et al.. (1989). Laboratory and clinical studies on cefdinir. Chemotherapy. 37. 603–611. 2 indexed citations
19.
Tateyama, Masao, et al.. (1989). Two Cases Reports of Septic Shock due to Vibrio vulnificus with Liver Cirrhosis. Kansenshogaku zasshi. 63(2). 156–161. 1 indexed citations
20.
Igari, J, et al.. (1987). Laboratory Evaluation of Leukocyte Esterase and Nitrite Tests for the Detection of Bacteriuria. Kansenshogaku zasshi. 61(6). 676–680. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026